Neurodevelopmental Disorder (Diagnosis)
13
5
6
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 13 trials
100.0%
+13.4% vs benchmark
8%
1 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (13)
Integration of New Generation Multi-omics Analyses for the Diagnosis of Genetic Neurodevelomental Disorders
Comparison of Synchronous and Asynchronous Action Observation Therapy in Children With Cerebral Palsy
Virtual Reality Headset as an Alternative Tool for Reducing Dental Anxiety
SAFE Early Intervention for At-Risk Infants
Transdiagnostic Dimensional Profiling of Neurodevelopmental Disorders
Feeding Disorders in Children
TAP-GRIN: Interventional Study on Patients With GRIN-related Neurodevelopmental Disorders
Characterization of Neurocognitive Profiles in Neurodevelopmental Disorders and Epilepsy: a Transdiagnostic Approach
Expanding NGS Data with Optical Genome Mapping (OGM)
Pai.ACT: AI-Driven ACT Chatbot for Mental Health Triage and Service Evaluation
NEOnatal Multiexposure to Medical Devices Plasticizers: Endocrine Disruption MIXture Effects and Neurodevelopmental Disorders
Smart Computing Models, Sensors, and Early Diagnostic Speech and Language Deficiencies Indicators in Child Communication
Optical Genome Mapping for the Diagnosis of Neurodevelopmental Disorders